Armistice Capital’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-57,597
| Closed | -$69.1K | – | 204 |
|
|
2025
Q1 | $69.1K | Sell |
57,597
-92,403
| -62% | -$111K | ﹤0.01% | 203 |
|
|
2024
Q4 | $255K | Sell |
150,000
-86,000
| -36% | -$146K | ﹤0.01% | 186 |
|
|
2024
Q3 | $555K | Sell |
236,000
-16,000
| -6% | -$37.6K | 0.01% | 184 |
|
|
2024
Q2 | $736K | Buy |
+252,000
| New | +$736K | 0.01% | 163 |
|
|
2022
Q2 | – | Sell |
-118,997
| Closed | -$2.57M | – | 181 |
|
|
2022
Q1 | $2.57M | Buy |
+118,997
| New | +$2.57M | 0.05% | 93 |
|
|
2021
Q3 | – | Sell |
-67,119
| Closed | -$6.73M | – | 136 |
|
|
2021
Q2 | $6.73M | Hold |
67,119
| – | – | 0.12% | 90 |
|
|
2021
Q1 | $10.2M | Buy |
67,119
+452
| +0.7% | +$68.7K | 0.23% | 74 |
|
|
2020
Q4 | $7.97M | Buy |
+66,667
| New | +$7.97M | 0.27% | 70 |
|
|
2020
Q1 | – | Sell |
-39,750
| Closed | -$7.73M | – | 77 |
|
|
2019
Q4 | $7.73M | Buy |
39,750
+14,150
| +55% | +$2.75M | 0.45% | 51 |
|
|
2019
Q3 | $6.2M | Buy |
25,600
+15,600
| +156% | +$3.78M | 0.41% | 44 |
|
|
2019
Q2 | $3.78M | Hold |
10,000
| – | – | 0.24% | 47 |
|
|
2019
Q1 | $3.34M | Buy |
10,000
+9,500
| +1,900% | +$3.17M | 0.18% | 55 |
|
|
2018
Q4 | $79K | Buy |
+500
| New | +$79K | 0.01% | 66 |
|
|
2018
Q2 | – | Sell |
-375
| Closed | -$956K | – | 70 |
|
|
2018
Q1 | $956K | Buy |
375
+283
| +308% | +$721K | 0.07% | 57 |
|
|
2017
Q4 | $818K | Buy |
+92
| New | +$818K | 0.08% | 59 |
|